Dolutegravir

ATC J05AJ03 · 10 markets · 64 records

Dolutegravir 10 markets · 64 records Forms

AU 11 records · 2 strengths

  • 50 mgtabletDovatoJuluca、JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle、Tivicay、Triumeq、TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle also in US·GB·CA +4 unknown

Records without a stated strength · 1 Dovato、Juluca、Tivicay、Tivicay PD、Triumeq +2

US 8 records · 4 strengths

GB 8 records · 4 strengths

CA 7 records · 2 strengths

  • 50 mgtabletDovatoJuluca、PMS-DOLUTEGRAVIR、SANDOZ DOLUTEGRAVIR、Tivicay、Triumeq also in AU·US·GB +4
  • 5 mgtabletTivicay also in US·GB·ES +1

ES 7 records · 3 strengths

TW 4 records · 2 strengths

  • 50 mgtabletTivicay汰威凱膜衣錠50毫克 also in AU·US·GB +4

Records without a stated strength · 1 Dovato、Juluca、Triumeq、三恩美膜衣錠、洛瓦梭膜衣錠、滋若愷膜衣錠 +3

EU 4 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 Dovato、Juluca、Tivicay、Triumeq +1

    CN 3 records · 2 strengths

    • 50 mgtablet特威凯多替拉韦 also in AU·US·GB +4
    • 5 mgtabletManufacturer: ViiV HealthcareBV also in US·GB·CA +1

    HK 3 records · 1 strengths

      Records without a stated strength · 1 Dovato、Tivicay、Triumeq

      MX 1 records · 1 strengths

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.